Carole S. Ben-Maimon
2012 - Impax Laboratories
In 2012, Carole S. Ben-Maimon earned a total compensation of $1.1M as Former President, Impax Generics Division at Impax Laboratories, a 23% decrease compared to previous year.
Compensation breakdown
| Bonus | $37,500 |
|---|---|
| Non-Equity Incentive Plan | $401,122 |
| Option Awards | $108,441 |
| Salary | $473,832 |
| Stock Awards | $90,560 |
| Other | $29,753 |
| Total | $1,141,208 |
Ben-Maimon received $473.8K in salary, accounting for 42% of the total pay in 2012.
Ben-Maimon also received $37.5K in bonus, $401.1K in non-equity incentive plan, $108.4K in option awards, $90.6K in stock awards and $29.8K in other compensation.
Rankings
In 2012, Carole S. Ben-Maimon's compensation ranked 5,612th out of 11,487 executives tracked by ExecPay. In other words, Ben-Maimon earned more than 51.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,612 out of 11,487 | 51st |
Division Manufacturing | 1,990 out of 4,253 | 53rd |
Major group Chemicals And Allied Products | 480 out of 1,203 | 60th |
Industry group Drugs | 321 out of 925 | 65th |
Industry Pharmaceutical Preparations | 251 out of 700 | 64th |
Source: SEC filing on April 14, 2015.
Ben-Maimon's colleagues
We found four more compensation records of executives who worked with Carole S. Ben-Maimon at Impax Laboratories in 2012.